Adynovate controls bleeding in real world for hemophilia A patients
In a real-world study in South Korea, preventive treatment with Adynovate (rurioctocog alfa pegol) was shown to be effective at preventing bleeding episodes among most children and adults with hemophilia A — findings that line up with those from clinical testing. In fact, “76.1% of patients on prophylactic…